Actively Recruiting
Optimization of MRI Sequences Used in the Study of Neurodegenerative Diseases
Led by University Hospital, Caen · Updated on 2023-07-03
40
Participants Needed
1
Research Sites
269 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Inserm NeuroPresage team has been using MRI for more than 20 years in the study of normal ageing and memory pathologies to further the understanding and the characterization of early diagnosis and the cerebral substrates of cognitive deficits in patients, particularly in the context of neurodegenerative diseases. Two years ago, a new 3T MRI camera was installed at the Cyceron centre. It is more efficient and should make it possible to obtain better quality images and/or to reduce the time required to acquire these images. In this context, it seems important to test the different sequences that we classically use in our studies, or that we plan to implement in our next studies (learning and text retrieval fMRI task), in order to optimize them, with a view to integrating them in our future studies.
CONDITIONS
Official Title
Optimization of MRI Sequences Used in the Study of Neurodegenerative Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy volunteers of legal age
- Affiliation with a social security scheme or beneficiary of such a scheme
- Signing of the protocol informed consent
- For women of childbearing age or capacity, a urine pregnancy test before inclusion
You will not qualify if you...
- Protected persons as defined by French Public Health Code articles L. 1121-5 to L.1121-8, including protected adults and pregnant or nursing women
- Contraindications to MRI examination without contrast agent injection
- Presence of chronic neurological or psychiatric conditions, including substance use disorder
- History of brain disease such as vascular, degenerative, malformative, tumor, or head trauma with loss of consciousness lasting more than one hour
- Current or recent use of medications that may interfere with imaging, including psychotropic drugs, antihistamines with anticholinergic effects, antiparkinsonian drugs, benzodiazepines including muscle relaxants, long-term steroidal anti-inflammatory drugs, antiepileptic drugs, or central painkillers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
GIP Cyceron
Caen, France, 14000
Actively Recruiting
Research Team
G
Géraldine Poisnel, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here